We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Tools, theory, progress
- NeuroS/T: assessment
- NeuroS/T: interventional
- NeuroS/T: derivative
- ‘Neuroweapons’
- NeuroS/T
- To what ends?
- Trans-human trajectories
- Technology…redux
- Neuroscience and technology on the 21st century global stage
- Contingencies
- Conclusion
- Join us next time for part 2 of 2
Topics Covered
- Neuroscience
- Biotechnology
- Neuroscience and Technology (NeuroS/T)
- NeuroS/T (assessment, intervention and derivative)
- Neuroweapons
- Bioengineering
- Genetics
- Pharmaceutical Sciences
- Biomedical Research
- Clinical Medicine
- Neurology
Links
Categories:
Therapeutic Areas:
Talk Citation
Giordano, J. (2022, August 30). Emerging neuroscience and technology: multinational enterprises on the 21st century global stage [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 4, 2024, from https://doi.org/10.69645/DRZL9598.Export Citation (RIS)
Publication History
Financial Disclosures
- There are no commercial financial matters and/or conflict(s) of interest to disclose. Prof. Giordano’s work is supported in part by funding from the Henry Jackson Foundation for Military Medicine; National Sciences Foundation Award 2113811 - Amendment ID 001; Award UL1TR001409 from the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health, through the Clinical and Translational Science Awards Program (CTSA), a trademark of the Department of Health and Human Services, part of the Roadmap Initiative, “Re-Engineering the Clinical Research Enterprise”; The Institute for Defense Analysis; Asklepios Biosciences; Veterans of War Foundation, and Leadership Initiatives.
Emerging neuroscience and technology: multinational enterprises on the 21st century global stage
Published on August 30, 2022
30 min
A selection of talks on Clinical Practice
Transcript
Please wait while the transcript is being prepared...
0:00
Hello. I'm Dr. James Giordano,
Professor in the Departments
of Neurology and Biochemistry
and Chief of the Neuroethics
Studies Program at
the Pellegrino Center
for Clinical Bioethics
at Georgetown University
Medical Center
in Washington DC., in
the United States.
Today we'll be discussing
emerging neuroscience
and technology.
The brain sciences and its
tools and applications
as multinational enterprises,
and the needs that these
enterprises foster
for globally relevant
neuroethics.
This is part one of
a two-part series.
We'll be discussing the
science and technology
of the 21st century
multinational stage.
0:38
If we can look at neuroscience
as almost any science
in technological engagement,
what we find is there's
an interesting dance.
A dance in which the
proverbial partners lead.
We begin with tools.
Those tools that are simple,
our own observation,
our own senses, and
what these mean
for our perceptions and
understanding of the world.
From this, we develop theories.
Those theories then
stand the relative test
of the development of new tools.
Not only to test those theories,
but to push the boundaries
of those theories,
gaining ever deeper knowledge
and further insight.
This generates progress.
This relative 'tools to theory'
and 'theory to tools' dance
provides a general heuristic,
a general pattern,
for development and
advancements in a variety of
different fields of
science and the tools,
literally rational
use of those tools,
technologies that they
prompt, generate,
necessitate and
this has certainly
been the case for
the brain sciences.
Taken together, these
tools and methods
provide us with the capability
to access the brain,
assess the brain, and
affect the brain structure
and its neurological functions.
In that way, it
allows us probably as
"low hanging fruit" to
define, evaluate, treat,
and in some cases prevent
pathologies, injuries,
diseases, or the
pathologization of those things
that occur as a consequence
of the human lifespan.
Congenital conditions and
changes in our capabilities,
perhaps as we age.
But at the heart of what it
is we're doing to define,
evaluate, treat, and prevent,
are the actual capabilities.
In other words, the first
principles, the raw truths,
of what these things can do.
These technologies and
our tools provide us with
the capability of not only
assessing the living brain,
in relatively real-time,
on a variety of levels,
from the cellular and
then extrapolating
that all the way to the social,
but also to engage what
it is the brain does
to alter sensations, thoughts,
emotions, decisions, and behaviors.
In other words, what we can
do is access the brain.
By accessing the
brain, we can assess
and affect what the brain does.
Colloquially, that is the mind.
Hide